Table 1.
Intra-laboratory reproducibilitya | |||
Xpert HPV – AML Run 2 | Total | ||
Xpert HPV –AML Run 1 | Negative | Positive | |
Negative | 353 | 4 | 357 |
Positive | 12 | 141 | 153 |
Total | 365 | 145 | 510 |
Inter-laboratory agreementb | |||
Xpert HPV UZ Ghent | Total | ||
Xpert HPV –AML Run 1 | Negative | Positive | |
Negative | 356 | 1 | 357 |
Positive | 10 | 143 | 153 |
Total | 366 | 144 | 510 |
Inter-laboratory agreementc | |||
Xpert HPV UZ Ghent | Total | ||
Xpert HPV –AML Run 2 | Negative | Positive | |
Negative | 154 | 3 | 357 |
Positive | 4 | 149 | 153 |
Total | 157 | 153 | 510 |
aThe overall HPV test agreement 96.9% (95% CI, 95.0–98.2%) KAPPA value of 0.925 (95% CI 0.888–0.961)
bThe overall HPV test agreement 97.8% (95% CI, 96.2–98.9%) KAPPA value of 0.948 (95% CI 0.917–0.978)
cThe overall HPV test agreement 98.6% (95% CI, 97.6–99.6%) KAPPA value of 0.967 (95% CI 0.943–0.991)